Closer surveillance of patients with IBD may entail earlier diagnosis (lead-time) of cases and overdiagnosis of colorectal cancer and that would not otherwise have surfaced clinically. Lead-time and overdiagnosis would make survival analyses which compare prognosis between IBD-related and IBD-unrelated colorectal cancer difficult to interpret.20 Therefore, the extent of colonoscopic surveillance – organized or opportunistic - should be reliably reported in all studies.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.